Semba Charles Pauling bought DMAC

June 1, 2024 · Form 4 insider transaction

Semba Charles Pauling bought 28,472 shares of DIAMEDICA THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

28,472

Price

$0.00

Total value

N/A

InsiderSemba Charles Pauling

RoleDirector

CompanyDIAMEDICA THERAPEUTICS INC (DMAC)

SecurityStock Option (right to buy)

Transaction codeA — Grant or award

Transaction dateJune 1, 2024

Filing dateJune 3, 2024

Shares owned after28,472

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Vests in four nearly equal quarterly installments over one year.

View the original Form 4 on SEC EDGAR